U.S. Senator Barbara Mikulski (D-MD) recently visited the U.S. Army Edgewood Chemical Biological Center (ECBC) for the ribbon cutting ceremony signifying the official opening of the recently completed Advanced Chemistry Laboratory. This state-of-the-art laboratory will safely advance defense research for emerging chemical threats.
Top officials from the World Health Organization, International Civil Aviation Organization, World Tourism Organization, Airports Council International, International Air Transport Association, and the World Travel and Tourism Council have activated a Travel and Transport Task Force to monitor the Ebola situation and provide timely information for travelers.
Argon Electronics has launched two new simulation probe kits, which enable users to temporarily convert real radiation meters into simulation detectors. This enhances radiological response training exercises: (a) on a standalone basis for indoor or outdoor exercises; or (b) with PlumeSIM, enabling users to create virtual tabletop/classroom and large-area field exercises.
Biometric-Signature Identification is a turnkey approach providing greater accuracy for online student verification. Biosignature authentication outshines personal identification numbers and passwords for verification of online enrollment and test-taking, while reducing financial aid fraud.
The Federal Railroad Administration recently funded two grants totaling $350,000 to support development of a Short Line Safety Institute. The Institute will help mitigate risk associated with rail shipments of hazardous materials by improving the culture of safety within the short line and regional rail industry as well as the industry's overall safety record.
The world experts on vaccine development at the University of Texas Medical Branch at Galveston have received an international designation acknowledging their unique niche in a sphere where research, government regulation and big pharma often collide.
UTMBs Sealy Center for Vaccine Development has been named a World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases.
Lawrence Livermore National Laboratory (LLNL) scientists have been selected to receive three regional awards for technology transfer by the Federal Laboratory Consortium. LLNL shared in awards for the development of a detector to identify explosives and drugs; for the development of a crystal to detect nuclear materials; and for the creation of a new tool to assist climate researchers.
The FSI® DAT®3060S is a three-line wide, 3 or 4 -station Mass Casualty Decon Shower System which handles two or three parallel lines of casualties at the same time in three or four sequential stations - (1) undress, (2) detergent shower #1 - (3) rinse shower #2 OR handle two personnel in separate showers simultaneously in each lane, (4) redress.
Soligenix, Inc., a clinical stage biopharmaceutical company, announced recently results demonstrating the improved immunogenicity and rapid action of its anthrax vaccine, VeloThrax. Previous studies had demonstrated that VeloThrax also possesses enhanced thermostability, enabling distribution without cold chain requirements.
An experimental vaccine to prevent the mosquito-borne viral illness chikungunya elicited neutralizing antibodies in all 25 adult volunteers who participated in a recent early-stage clinical trial conducted by researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
